Quantum Biopharma (QNTM) EBITDA (2019 - 2026)
Quantum Biopharma recorded quarterly EBITDA of -$13.6 million in Q1 2026, down 474.31% quarter-over-quarter from -$2.4 million in Q4 2025, and down 55.9% year-over-year from -$30.9 million in Q1 2025.
Quantum Biopharma's EBITDA history runs 8 years deep, the most recent figure standing at -$13.6 million for Q1 2026.
- In Q1 2026, EBITDA fell 55.9% year-over-year to -$13.6 million; the TTM figure through Mar 2026 stood at -$30.3 million (down 72.55% YoY), while the FY2025 annual figure was -$15.3 million, up 5.17% from the prior year.
- EBITDA came in at -$13.6 million for Q1 2026 at Quantum Biopharma, down from -$2.4 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $25.3 million in Q2 2023 to a low of -$13.6 million in Q1 2026.
- A 5-year average of -$2.6 million and a median of -$3.4 million in 2024 frame the typical range for EBITDA.
- On a YoY basis, EBITDA climbed as much as 76.62% in 2024 and fell as far as 278.05% in 2024.
- Quantum Biopharma's EBITDA stood at $6.0 million in 2022, then slumped by 220.6% to -$7.2 million in 2023, then jumped by 70.99% to -$2.1 million in 2024, then fell by 13.48% to -$2.4 million in 2025, then tumbled by 474.31% to -$13.6 million in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$13.6 million, -$2.4 million, and -$4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 201.19 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -445.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.63 Mn |
| Dec 31, 2025 | -2.37 Mn |
| Sep 30, 2025 | -4.60 Mn |
| Jun 30, 2025 | -9.68 Mn |
| Mar 31, 2025 | -8.74 Mn |
| Dec 31, 2024 | -2.09 Mn |
| Sep 30, 2024 | -3.27 Mn |
| Jun 30, 2024 | -3.45 Mn |
| Mar 31, 2024 | -2.32 Mn |
| Dec 31, 2023 | -7.21 Mn |
| Sep 30, 2023 | -863,852.00 |
| Jun 30, 2023 | 25.29 Mn |
| Mar 31, 2023 | -9.94 Mn |
| Mar 31, 2022 | 5.98 Mn |
| Jun 30, 2021 | -13.25 Mn |
| Mar 31, 2021 | 9.98 Mn |
| Sep 30, 2020 | -13.81 Mn |
| Jun 30, 2020 | -4.83 Mn |
| Mar 31, 2020 | -8.07 Mn |
| Dec 31, 2019 | -11.51 Mn |
| Mar 31, 2019 | -1.73 Mn |